Lung Cancers Unknown Status Phase 2 Trials for Gefitinib (DB00317)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01024712Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00616499Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung CancerTreatment